258 related articles for article (PubMed ID: 28477733)
21. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
22. Estrogen replacement in women of fertile years with hypopituitarism.
Mah PM; Webster J; Jönsson P; Feldt-Rasmussen U; Koltowska-Häggström M; Ross RJ
J Clin Endocrinol Metab; 2005 Nov; 90(11):5964-9. PubMed ID: 16091478
[TBL] [Abstract][Full Text] [Related]
23. MECHANISMS IN ENDOCRINOLOGY: Paracrine and endocrine control of the growth hormone axis by estrogen.
Birzniece V; Ho KKY
Eur J Endocrinol; 2021 May; 184(6):R269-R278. PubMed ID: 33852424
[TBL] [Abstract][Full Text] [Related]
24. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
25. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.
Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA
Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915
[TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
27. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
[TBL] [Abstract][Full Text] [Related]
28. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
30. Estrogen regulation of growth hormone action.
Leung KC; Johannsson G; Leong GM; Ho KK
Endocr Rev; 2004 Oct; 25(5):693-721. PubMed ID: 15466938
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence.
Metzger DL; Kerrigan JR
J Clin Endocrinol Metab; 1994 Aug; 79(2):513-8. PubMed ID: 8045971
[TBL] [Abstract][Full Text] [Related]
32. A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health.
Southmayd EA; De Souza MJ
Growth Horm IGF Res; 2017 Feb; 32():2-13. PubMed ID: 27693042
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: evidence for independent actions of estrogen and androgen.
Metzger DL; Kerrigan JR
J Clin Endocrinol Metab; 1993 May; 76(5):1147-52. PubMed ID: 8496305
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone: a regulator of the sexually differentiated steroid metabolism in rat liver.
Gustafsson JA; Mode A; Norstedt G; Eneroth P; Hökfelt T
Prog Clin Biol Res; 1983; 135():37-59. PubMed ID: 6665012
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
36. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
[TBL] [Abstract][Full Text] [Related]
37. Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver.
Birzniece V; Meinhardt UJ; Umpleby MA; Handelsman DJ; Ho KK
J Clin Endocrinol Metab; 2011 Apr; 96(4):1060-7. PubMed ID: 21239519
[TBL] [Abstract][Full Text] [Related]
38. Route-dependent endocrine and metabolic effects of estrogen replacement therapy.
O'Sullivan AJ; Ho KK
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1457-66. PubMed ID: 11202222
[TBL] [Abstract][Full Text] [Related]
39. The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy.
Ho KK; O'Sullivan AJ; Burt MG
J Endocrinol; 2023 May; 257(2):. PubMed ID: 36524723
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone and sex steroids. Interactions in puberty.
Mauras N
Endocrinol Metab Clin North Am; 2001 Sep; 30(3):529-44. PubMed ID: 11571929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
